Down's syndrome. Central monoamine turnover in patients with diminished platelet serotonin.
D000293:Adolescent; D000328:Adult; D001792:Blood Platelets / Q000378:metabolism*; D002648:Child; D004314:Down Syndrome / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008297:Male; D008875:Middle Aged; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism*
D010648:Phenylacetates; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid